GSK admits fault and will lower its prices in China

British drug giant GlaxoSmithKline (GSK) will lower the prices of its products on the mainland and has admitted that some of its senior executives appear to have broken the law there.

Meanwhile, the mainland's crackdown on pharmaceutical firms widened to AstraZeneca.

The Shanghai office of the Anglo-Swedish firm was visited by the Shanghai Public Security Bureau "regarding a local police matter focused on a sales representative", a spokesman for the company said. "This investigation relates to an individual case."

via Business feed http://www.scmp.com/news/china/article/1288757/gsk-admits-fault-and-will-lower-its-prices-mainland